Yun-Bae Kim

Prof. Yun-Bae Kim

Chungbuk National University, Cheongju-si, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
IPIn Yup Park
In Yup Park
JCJu Hyun Cho
Ju Hyun Cho
KKKey Sun Kim
Key Sun Kim
Yun-Bae KimYun-Bae Kim
Yun-Bae Kim
MKMi Sun Kim
Mi Sun Kim
SKSun Chang Kim
Sun Chang Kim
Salt sensitivity of antimicrobial peptides poses a major obstacle in their development as novel antibiotics. Here we report the use of helix-capping motifs to confer salt resistance upon helical antimicrobial peptides. The helical content of the template peptide [RLLR]5 was almost completely destroyed at salt concentrations over 200 mm NaCl, leading to a 8–32-fold decrease in antimicrobial activity. However, the introduction of helix-capping motifs at the helix termini resulted in a structurally stable peptide, which retained membrane-permeabilizing and antimicrobial activities upon exposure to salt. Furthermore, the peptide with helix-capping motifs directly inhibited the in vivo growth of Streptococcus pyogenes, which causes localized fasciitis in mice, and prevented the necrosis of the epidermis, dermis, and subcutaneous muscle layers. Results indicate that the adoption of helix-capping motifs into salt-sensitive antimicrobial peptides provides the necessary structural stability for the peptides to permeabilize cell membranes and cause cell death at physiological salt concentrations.

12 December 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
HYH-M Yun
H-M Yun
HKH S Kim
H S Kim
KPK-R Park
K-R Park
JSJ M Shin
J M Shin
AKA R Kang
A R Kang
JHJin Tae Hong
Jin Tae Hong
Mesenchymal stem cells (MSCs) promote functional recoveries in pathological experimental models of central nervous system (CNS) and are currently being tested in clinical trials for neurological disorders, but preventive mechanisms of placenta-derived MSCs (PD-MSCs) for Alzheimer’s disease are poorly understood. Herein, we investigated the inhibitory effect of PD-MSCs on neuronal cell death and memory impairment in Aβ1–42-infused mice. After intracerebroventrical (ICV) infusion of Aβ1–42 for 14 days, the cognitive function was assessed by the Morris water maze test and passive avoidance test. Our results showed that the transplantation of PD-MSCs into Aβ1–42-infused mice significantly improved cognitive impairment, and behavioral changes attenuated the expression of APP, BACE1, and Aβ, as well as the activity of β-secretase and γ-secretase. In addition, the activation of glia cells and the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) were inhibited by the transplantation of PD-MSCs. Furthermore, we also found that PD-MSCs downregulated the release of inflammatory cytokines as well as prevented neuronal cell death and promoted neuronal cell differentiation from neuronal progenitor cells in Aβ1–42-infused mice. These data indicate that PD-MSC mediates neuroprotection by regulating neuronal death, neurogenesis, glia cell activation in hippocampus, and altering cytokine expression, suggesting a close link between the therapeutic effects of MSCs and the damaged CNS in Alzheimer’s disease.

1 January 2014 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
ILIn-Chul Lee
In-Chul Lee
SKSung-Hwan Kim
Sung-Hwan Kim
HBHyung-Seon Baek
Hyung-Seon Baek
CMChangjong Moon
Changjong Moon
SKSeong-Soo Kang
Seong-Soo Kang
Jong-Choon KimJong-Choon Kim
Jong-Choon Kim

1 April 2012 in Experimental Neurology
Verified
Journal Article
Closed access
DPDongsun Park
Dongsun Park
HLHong Jun Lee
Hong Jun Lee
SJSeong Soo Joo
Seong Soo Joo
DBDae-Kwon Bae
Dae-Kwon Bae
GYGoeun Yang
Goeun Yang
SKSeung U. Kim
Seung U. Kim

1 November 2013 in Neurobiology of Aging
Verified
Journal Article
Closed access
DPDongsun Park
Dongsun Park
YYYun-Hui Yang
Yun-Hui Yang
DBDae Kwon Bae
Dae Kwon Bae
SLSun Hee Lee
Sun Hee Lee
GYGoeun Yang
Goeun Yang
Yun-Bae KimYun-Bae Kim
Yun-Bae Kim

1 January 2008 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
SJSeong Soo Joo
Seong Soo Joo
YYYeong Min Yoo
Yeong Min Yoo
BAByung Woo Ahn
Byung Woo Ahn
SNSang Yun Nam
Sang Yun Nam
Yun-Bae KimYun-Bae Kim
Yun-Bae Kim
DLDo Ik Lee
Do Ik Lee
Considering the importance of inflammation and apoptosis in neurodegenerative conditions, the potential suppressive effects of the Rg3, a by-product obtained during the steaming of red ginseng, may indicate that Rg3 could provide a beneficial therapeutic approach to treating or preventing neurodegenerative disease. We investigated the effect of Rg3 on Aβ42-mediated microglial activation and inflammation-mediated neurotoxicity in murine BV-2 microglial and Neuro-2a neuroblastoma cells, respectively. Rg3 effectively reduced inflammatory cytokine expression in Aβ42-treated BV-2, and inhibited the binding of NF-κB p65 to its DNA consensus sequences, and significantly reduced the expression of TNF-α in activated microglia. Pretreatment with Rg3 increased the survival rate of Neuro-2a exposed to TNF-α. These observations suggest that Rg3 reduced neurotoxicity by inhibiting chronic inflammation through the suppression of activated microglia. In addition, the expression of pro-inflammatory cytokines in BV-2 stimulated by Aβ42 was decreased but not eliminated by Rg3 when binding to the macrophage scavenger receptor type A (MSRA) was blocked with fucoidan. This implies that the inflammatory response may not be exclusively triggered via MSRA. More interestingly, iNOS was almost completely inhibited in the presence of Rg3 when MSRA binding was blocked with fucoidan. Moreover, Rg3 increased the expression of MSRA in BV-2 transfected with siRNA targeting MSRA mRNA, and this increased MSRA expression may play a role in the phagocytosis of Aβ42 peptides. Our results indicate that inhibition of the inflammatory repertoire of microglia, neuroprotection, and increased MSRA expression induced by Rg3 may at least partly explain its therapeutic effects in chronic neurodegenerative diseases.